Accreditation/Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 1.5 Contact Hours.

This activity, COPE Activity Number 122355, is accredited by COPE for continuing education for optometrists.

Acknowledgment of Support

This activity is supported by an educational grant from Dompé U.S., Inc.

Medical Crossfire®: Expert Perspectives in Neurotrophic Keratitis – Updates in Optimal Treatment Strategies & Emphasizing Importance of Early Intervention

Release Date: August 31, 2021
Expiration Date: August 31, 2022

Activity Overview

The Medical Crossfire™, one of PER’s signature educational formats, is a video-based program in which a panel of distinguished experts engage in spirted discussions and debates on a particular clinical topic. In this activity, 4 key thought leaders explore the latest data regarding current and emerging therapeutic strategies for the management of neurotrophic keratitis (NK). This lively discussion will help place new developments into clinical context to help you optimize care for your patients with or at risk for this eye disease.

Acknowledgement of Commercial Support

This activity is supported by an educational grant from Dompé U.S., Inc.

Instructions for This Activity and Receiving Credit

  1. Complete the activity (including pre- and post-activity assessments).
  2. Answer the evaluation questions.
  3. Request credit using the drop-down menu.

You may immediately download your certificate.


Target Audience

This online educational activity is directed toward ophthalmologists, optometrists, and other health care professionals involved in the treatment of patients with NK.

Learning Objectives

At the conclusion of this activity, you should be better prepared to:

  • Explain the role of the trigeminal and corneal sensory nerves in the normal function of the cornea
  • Summarize the diseases and injuries that commonly cause NK
  • Apply appropriate testing strategies in support of a timely diagnosis of NK
  • Develop evidence-based treatment plans for patients with NK based on disease stage

Faculty, Staff, and Planners’ Disclosures

The staff of Physicians’ Education Resource®, LLC have no relevant financial relationships with ineligible entities.

Chair

Francis S. Mah, MD
Francis S. Mah, MD
Director of Cornea and External Disease
Co-Director, Refractive Surgery
Scripps Clinic Medical Group
La Jolla, CA

Disclosures: Consultant: Allergan; Novartis; Ocular Science.

Faculty

Preeya K. Gupta, MD
Preeya K. Gupta, MD
Medical Director, Triangle Eye Consultants
Chef Medical Adviser, Surface Opthalmics, Inc.
Co-Founder, Interventional Mindset
Durham, NC

Disclosures: Consultant: Alcon, Allergan, HanAll Biopharma, Johnson & Johnson Vision, Kala Pharmaceuticals, New World Medical, Novartis, Ocular Therapeutix, Oyster Point Pharma, Inc., Sight Sciences, Surface Ophthalmics, Inc., Sun Inc., Tear Lab Corporation, TissueTech, Inc., Zeiss International.

Edward J. Holland, MD
Edward J. Holland, MD
Professor of Clinical Ophthalmology
University of Cincinnati
Director of Cornea Services
Cincinnati Eye Institute
Cincinnati, OH

Disclosures: Consultant: Chief Medical Adviser, Aurion Biotech, Inc., Dompé.

Stephen C. Pflugfelder, MD
Stephen C. Pflugfelder, MD
Professor, James and Margaret Elkins Chair
Director, Ocular Surface Center at the Cullen Eye Institute,
Department of Ophthalmology
Baylor College of Medicine
Houston, TX

Disclosures: Grant/Research Support: Dompe; Consultant: Kala, Dompe, Novartis, Kowa, Senju Pharmaceutical Co, Ltd.

PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a healthcare professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.


Login or Register to Start Activity

Please use the form below to Register or Log In to begin Activity.

*Required Fields
Calendar of Events
SUNMONTUESWEDTHURSFRISAT
 123456
78910111213
14151617181920
21222324252627
28293031
Filter By